BPC-157 vs TB-500: A Research Comparison
A neutral research overview of two peptides studied side by side in tissue-repair and regeneration models — origin, mechanism, and research considerations.
BPC-157 and TB-500 are two of the most frequently studied peptides in tissue-repair and regenerative research, and they are often examined side by side. Although both have been investigated in models of healing and recovery, they are structurally distinct molecules with different proposed mechanisms. This overview compares what the preclinical literature describes about each — strictly as laboratory research compounds.
| BPC-157 | TB-500 | |
|---|---|---|
| Origin | Synthetic pentadecapeptide derived from a gastric protein sequence | Synthetic fragment of the protein Thymosin Beta-4 |
| Length | 15 amino acids | ~7-amino-acid active region |
| Mechanism studied | Angiogenesis and growth-factor signalling in tissue models | Actin regulation and cell migration |
| Research areas | Gut, tendon, and connective-tissue models | Cell-migration and tissue-organisation models |
| Format | Lyophilised vial | Lyophilised vial |
BPC-157 — research overview
BPC-157 is a synthetic peptide studied in preclinical models for its role in angiogenesis (the formation of new blood vessels) and growth-factor signalling pathways. Much of the published research focuses on gastrointestinal and connective-tissue models.
TB-500 — research overview
TB-500 is a synthetic fragment corresponding to the active region of Thymosin Beta-4, a naturally occurring protein. In research settings it is studied for its interaction with actin, a cytoskeletal protein involved in cell migration and tissue organisation.
Key differences researchers note
The two are mechanistically different: BPC-157 research centres on vascular and growth-factor pathways, while TB-500 research centres on actin-mediated cell migration. Because of these complementary mechanisms, some research designs examine them in parallel rather than as substitutes. For a broader look at this research area, see our overview of regenerative peptides in sports-injury research.
Research considerations
Both compounds are third-party tested by HPLC and LC-MS and shipped with a Certificate of Analysis. As with all lyophilised peptides, handling and reconstitution affect stability — see our reconstitution guide, verify any batch on our verification hub, or review the aggregate Quality Report.
*Research use only. BPC-157 and TB-500 are sold strictly for in vitro laboratory research and are not for human or veterinary use.*